Literature DB >> 17202350

Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance.

Sarah E Cabbage1, Eric S Huseby, Blythe D Sather, Thea Brabb, Denny Liggitt, Joan Goverman.   

Abstract

The pathogenesis of multiple sclerosis involves a breakdown in T cell tolerance to myelin proteins like myelin basic protein (MBP). Most MBP-specific T cells are eliminated by central tolerance in adult mice, however, the developmentally regulated expression of MBP allows MBP-specific thymocytes in young mice to escape negative selection. It is not known how these T cells that encounter MBP for the first time in the periphery are regulated. We show that naive MBP-specific T cells transferred into T cell-deficient mice induce severe autoimmunity. Regulatory T cells prevent disease, however, suppression of the newly transferred MBP-specific T cells is abrogated by activating APCs in vivo. Without APC activation, MBP-specific T cells persist in the periphery of protected mice but do not become anergic, raising the question of how long-term tolerance can be maintained if APCs presenting endogenous MBP become activated. Our results demonstrate that regulatory T cells induce naive MBP-specific T cells responding to nonactivated APCs to differentiate into a unique, tolerized state with the ability to produce IL-10 and TGF-beta1 in response to activated, but not nonactivated, APCs presenting MBP. This tolerant response depends on continuous activity of regulatory T cells because, in their absence, these uniquely tolerized MBP-specific T cells can again induce autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202350     DOI: 10.4049/jimmunol.178.2.887

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

Authors:  Margaret S Bynoe; Paula Bonorino; Christophe Viret
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

2.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

3.  Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis.

Authors:  Hong Zhang; Joseph R Podojil; Xunrong Luo; Stephen D Miller
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Regulatory T cells in CNS injury: the simple, the complex and the confused.

Authors:  James T Walsh; Jonathan Kipnis
Journal:  Trends Mol Med       Date:  2011-07-07       Impact factor: 11.951

Review 5.  Immune tolerance in multiple sclerosis.

Authors:  Joan M Goverman
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

6.  CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis.

Authors:  Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2011-05-06       Impact factor: 5.422

7.  Loss of β-arrestin 2 exacerbates experimental autoimmune encephalomyelitis with reduced number of Foxp3+ CD4+ regulatory T cells.

Authors:  Yu Zhang; Chang Liu; Bin Wei; Gang Pei
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

Review 8.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

9.  Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs.

Authors:  Qingyong Ji; Antoine Perchellet; Joan M Goverman
Journal:  Nat Immunol       Date:  2010-06-06       Impact factor: 25.606

10.  Lymphopenia-induced proliferation is a potent activator for CD4+ T cell-mediated autoimmune disease in the retina.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.